Acasă › Cancer de sân › Ohio › Cincinnati
Studii clinice pentru Cancer de sân în Cincinnati, OH
25 studii pentru Cancer de sân caută participanți în și în jurul orașului Cincinnati (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
În curs de recrutareStudiu observaționalVoluntari sănătoși bineveniți
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- și încă 3
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
În curs de recrutareFaza 3
- TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020), Cincinnati
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
În curs de recrutareFaza 3
- Good Samaritan Hospital-TriHealth Cancer institute ( Site 0027), Cincinnati
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
În curs de recrutareFaza 3
- Saint Elizabeth Medical Center Edgewood-Cancer Care Center ( Site 0053), Edgewood · La 8 mi distanță
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
În curs de recrutareFaza 3
- University of Cincinnati Medical Center, Cincinnati
- University of Cincinnati Medical Center - West Chester Hospital, West Chester · La 15 mi distanță
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
În curs de recrutareFaza 3
- Research Site, Cincinnati
- Research Site, Cincinnati
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
În curs de recrutareFaza 3
- Clinical Trial Site, Cincinnati
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
În curs de recrutareFaza 3
- Saint Elizabeth Medical Center Edgewood, Edgewood · La 8 mi distanță
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
În curs de recrutareFaza 3
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · La 15 mi distanță
A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
În curs de recrutareFaza 3
- Research Site, Edgewood · La 8 mi distanță
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
În curs de recrutareFaza 1/2
- University of Cincinnati Medical Center, Cincinnati
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
În curs de recrutareStudiu observațional
- University of Cincinnati Medical Center, Cincinnati
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
În curs de recrutareFaza 3
- The Christ Hospital, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- și încă 2
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
În curs de recrutareFaza 1
- St. Elizabeth Healthcare, Edgewood · La 8 mi distanță
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
În curs de recrutareFaza 3
- Oncology Hematology Care, Cincinnati
E-Mindfulness Approaches for Living After Breast Cancer
În curs de recrutareFaza 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · La 15 mi distanță
Intraoperative Neuromonitoring (IONM) and Bipolar Electrocautery (BE) During Axillary Lymph Node Dissection (ALND)
În curs de recrutare
- University of Cincinnati, Cincinnati
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
În curs de recrutareFaza 2
- The Christ Hospital Cancer Center, Cincinnati
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
În curs de recrutareFaza 3
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · La 15 mi distanță
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Carl & Edyth Lindner Center for Research & Education at The Christ Hospital and The Christ Hospital Cancer Center, Cincinnati
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
În curs de recrutareStudiu observațional
- St. Elizabeth Edgewood Hospital, Edgewood · La 8 mi distanță
Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks
În curs de recrutareFaza 4
- University of Cincinnati Medical Center, Cincinnati
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
În curs de recrutareStudiu observațional
- Massive Bio SYNERGY-AI site, Cincinnati
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
În curs de recrutareFaza 3
- The Christ Hospital, Cincinnati
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · La 15 mi distanță
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
În curs de recrutareStudiu observațional
- TriHealth Cancer Institutes, Cincinnati
- Oncology Hematology Care, Cincinnati
Studii pentru Cancer de sân în alte orașe
- New York City, NY134 studii
- Houston, TX126 studii
- Boston, MA111 studii
- Nashville, TN80 studii
- Los Angeles, CA72 studii
- Edison, NJ68 studii
- St. Louis, MO64 studii
- Durham, NC63 studii
- Queens, NY63 studii
- Chicago, IL58 studii
- Philadelphia, PA56 studii
- Dallas, TX55 studii
Alte studii în Cincinnati
- Cancer pulmonar cu celule non-pătrate35 studii
- Cancer (toate tipurile)27 studii
- Insuficiență cardiacă24 studii
- Cancer colorectal21 studii
- Leucemie mieloasă acută20 studii
- Cancer metastatic20 studii
- Cancer ovarian19 studii
- Cancer pulmonar19 studii
- Obezitate19 studii
- Cancer de prostată18 studii
- Mielom multiplu17 studii
- Melanom17 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.